BioCentury
ARTICLE | Clinical News

Ropinirole: Phase III started

May 11, 2015 7:00 AM UTC

Hisamitsu began a double-blind, Japanese Phase III trial of once-daily transdermal HP-3000 in patients receiving L-dopa. Patients will receive HP-3000 plus an oral placebo; once-daily oral ropinirole ...